Hydroxyzine Pamoate Capsule
Product Images NDC 43063-172

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydroxyzine Pamoate (NDC 43063-172). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (43063172)

Label for hydroxyzine pamoate 25 mg capsules from PD-Rx Pharmaceuticals, Inc. The label shows a package containing 4 capsules. The product is identified as hydroxyzine pamoate USP, equivalent to hydroxyzine hydrochloride 25 mg. The NDC is 43063-172-04. The label includes usage warnings such as potential drowsiness and advises caution while driving or performing tasks requiring mental alertness. There is a barcode, QR code, lot number H20A32, and expiration date 08/2022.*

FDA Label Image

Chemical Structure (Hypam 01)

Chemical structure diagram of hydroxyzine pamoate showing its molecular components and bonding arrangement.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.